|
⚲
|
| Keyboard |
| Harshbarger Benjamin
✚
|
|
|---|---|
| CIK # | 0001653133 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001653133] | |
| 4 | [0001653133] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Catabasis Pharmaceuticals Inc | |
| Harshbarger Benjamin | |
| Novelion Therapeutics Inc | |
| Aegerion Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2026-01-23 | Disposed to issuer | 55,000 | ||
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2026-01-23 | Disposed to issuer | 33,333 | ||
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2026-01-23 | Disposed to issuer | 262,500 | ||
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2025-03-21 | Grant | 262,500 | $0.00 | |
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2024-02-08 | Grant | 175,000 | $0.00 | |
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (Right to Buy) · derivative
|
2023-06-02 | Grant | 90,000 | $0.00 | |
|
Catabasis Pharmaceuticals Inc ATXS
Stock Option (right to buy) · derivative
|
2022-03-01 | Grant | 55,000 | $0.00 | |
|
Catabasis Pharmaceuticals Inc CATB
Stock Option (right to buy) · derivative
|
2021-06-08 | Grant | 200,000 | $0.00 | |
|
Catabasis Pharmaceuticals Inc CATB
Stock Option (right to buy) · derivative
|
2021-06-02 | Grant | 400,000 | $0.00 | |
|
Catabasis Pharmaceuticals Inc CATB
Stock Option (right to buy) · derivative
|
2020-06-11 | Grant | 45,000 | $0.00 | |
|
Novelion Therapeutics Inc NVLN
Common Stock
|
2019-05-09 | Tax withheld | 212 | $1.22 | 259 |
|
Novelion Therapeutics Inc NVLN
Common Stock
|
2018-09-17 | Tax withheld | 98 | $3.94 | 386 |
|
Novelion Therapeutics Inc NVLN
Common Stock
|
2018-05-15 | Tax withheld | 150 | $4.15 | 622 |
|
Novelion Therapeutics Inc NVLN
Common Stock
|
2018-05-09 | Tax withheld | 322 | $4.26 | 1,372 |
|
Novelion Therapeutics Inc NVLN
Common Stock
|
2018-04-01 | Tax withheld | 52 | $3.50 | 182 |
|
Novelion Therapeutics Inc NVLN
Stock Option (Right to Buy) · derivative
|
2018-02-12 | Grant | 45,000 | $0.00 | |
|
Novelion Therapeutics Inc NVLN
Stock Option (Right to Buy) · derivative
|
2017-10-06 | Grant | 75,000 | $0.00 | |
|
Novelion Therapeutics Inc NVLN
Common Shares
|
2017-09-17 | Option exercise | 337 | ||
|
Novelion Therapeutics Inc NVLN
Common Shares
|
2017-09-17 | Tax withheld | 109 | $7.08 | 772 |
|
Novelion Therapeutics Inc NVLN
Restricted Stock Units · derivative
|
2017-09-17 | Option exercise | 337 | $0.00 | |
| showing 20 of 66 most recent transactions | |||||